Supernus Pharmaceuticals | Passività Correnti



Current Liabilities Cambiamento Data
Abbott USD 13B 1.15B 2025-03
ANI Pharmaceuticals USD 201.82M 8.14M 2025-03
Aurora Cannabis CAD 149.81M 40.71M 2024-12
Bristol-Myers Squibb USD 24.07B 296M 2025-03
Canopy Growth CAD 97.02M 184.27M 2024-12
Corcept Therapeutics USD 143.07M 2.29M 2025-03
Eisai JPY 372.29B 9.32B 2025-03
Eli Lilly USD 30.07B 1.69B 2025-03
Indivior 1.01B 66M 2025-03
Novo Nordisk 236.12B 27.76B 2025-03
Pacira USD 314.73M 4.81M 2025-03
Perrigo USD 1.07B 29.6M 2025-03
Pfizer USD 36.45B 6.54B 2025-03
Supernus Pharmaceuticals USD 292.4M 889K 2024-12
United Therapeutics USD 721.5M 16.6M 2025-03
Xeris Pharmaceuticals USD 100.44M 9.43M 2024-12



Supernus Pharmaceuticals Passività Correnti - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - May 2025.